Interaction of Human Lactoferrin with Cell Adhesion Molecules through RGD Motif Elucidated by Lactoferrin-binding Epitopes*
暂无分享,去创建一个
Kotaro Sakamoto | Yuji Ito | K. Sugimura | Toshiyuki Mori | Toshiyuki Mori | Yuji Ito | Kazuhisa Sugimura | Kotaro Sakamoto
[1] E. Burstein,et al. Protein F1 is required for efficient entry of Streptococcus pyogenes into epithelial cells. , 1998, The Journal of infectious diseases.
[2] M. Chance,et al. Structural reorganization of the transferrin C-lobe and transferrin receptor upon complex formation: the C-lobe binds to the receptor helical domain. , 2003, Biochemistry.
[3] H. Koeffler,et al. Molecular Cloning of Transferrin Receptor 2 , 1999, The Journal of Biological Chemistry.
[4] S. Kaneko,et al. Hepatitis C virus envelope proteins bind lactoferrin , 1997, Journal of virology.
[5] C. Joe,et al. Lactoferrin works as a new LPS-binding protein in inflammatory activation of macrophages. , 2004, International immunopharmacology.
[6] Y. Suzuki,et al. Molecular cloning and functional expression of a human intestinal lactoferrin receptor. , 2001, Biochemistry.
[7] Mathieu Carpentier,et al. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. , 2004, European journal of biochemistry.
[8] H. Nomoto,et al. Orally administered bovine lactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: a possible explanation for inhibition of carcinogenesis and metastasis. , 2004, Cytokine.
[9] H. Ashino,et al. Bovine lactoferrin inhibits tumor‐induced angiogenesis , 2004, International journal of cancer.
[10] Jen-Ren Wang,et al. Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells. , 2005, Antiviral research.
[11] Renhao Li,et al. Use of phage display to probe the evolution of binding specificity and affinity in integrins. , 2003, Protein engineering.
[12] A. Amoroso,et al. Review: Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application , 2002, Journal of endotoxin research.
[13] P. Newman,et al. Integrin Activation by Regulated Dimerization and Oligomerization of Platelet Endothelial Cell Adhesion Molecule (Pecam)-1 from within the Cell , 2001, The Journal of cell biology.
[14] I. Mattsby‐Baltzer,et al. Orally administered bovine lactoferrin systemically inhibits VEGF165-mediated angiogenesis in the rat , 2001 .
[15] H. Overkleeft,et al. Solid-phase synthesis of cyclic RGD-furanoid sugar amino acid peptides as integrin inhibitors. , 2003, Bioorganic & medicinal chemistry letters.
[16] V. Salmon,et al. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells. , 1997, The Biochemical journal.
[17] Thomas Walz,et al. Structure of the Human Transferrin Receptor-Transferrin Complex , 2004, Cell.
[18] L. Szekely,et al. Endogenous fibronectin of blood polymorphonuclear leukocytes: immunochemical characterization and subcellular localization. , 1997, Experimental cell research.
[19] G. Forni,et al. Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy , 2004, International journal of cancer.
[20] V. Salmon,et al. Lactoferrin Inhibits the Endotoxin Interaction with CD14 by Competition with the Lipopolysaccharide-Binding Protein , 1998, Infection and Immunity.
[21] M. Harmsen,et al. Antiviral activities of lactoferrin. , 2001, Antiviral research.
[22] S. Sugai,et al. Analyses for binding of the transferrin family of proteins to the transferrin receptor 2 , 2004, British journal of haematology.
[23] B. Ohlsson,et al. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κB , 2002 .
[24] P. V. van Berkel,et al. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. , 1997, The Biochemical journal.